Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-21

Clinical Trial Update: Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating topical trichloroacetic acid for actinic cheilitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trichloroacetic acid (trichloroacetic acid)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Actinic Cheilitis | Phase 4 | Status: WITHDRAWN